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Pre-hospital treatment of bee and wasp
induced anaphylactic reactions: a
retrospective study
Athamaica Ruiz Oropeza1*, Søren Mikkelsen2, Carsten Bindslev-Jensen1 and Charlotte G. Mortz1
Abstract
Background: Bee and wasp stings are among the most common triggers of anaphylaxis in adults representing
around 20% of fatal anaphylaxis from any cause. Data of pre-hospital treatment of bee and wasp induced anaphylactic
reactions are sparse. This study aimed to estimate the incidence of bee and wasp induced anaphylactic reactions, the
severity of the reactions and to correlate the pre-hospital treatment with the severity of the anaphylactic reaction.
Methods: Retrospective and descriptive study based on data from the Mobile Emergency Care Units (MECUs) in the
Region of Southern Denmark (2008 only for Odense and 2009–2014 for the whole region). Discharge summaries with
diagnosis related to anaphylaxis according to the International Classification of Diseases 10 (ICD-10) were reviewed to
identify bee and wasp induced anaphylactic reactions. The severity of the anaphylactic reaction was assessed according
to Sampson’s severity score and Mueller’s severity score. Treatment was evaluated in relation to administration of
adrenaline, glucocorticoids and antihistamine.
Results: We identified 273 cases (Odense 2008 n = 14 and Region of Southern Denmark 2009–2014 n = 259) of bee and
wasp induced anaphylaxis. The Incidence Rate was estimated to 35.8 cases per 1,000,000 person year (95% CI 25.9–48.2)
in the Region of Southern Denmark during 2009–2014. According to Sampson’s severity score, 65% (n = 177) of the
cases were graded as moderate to severe anaphylaxis (grade 3–5). Almost one third of cases could not be graded
according to Mueller’s severity score. Adrenaline was administrated in 54% (96/177) of cases with moderate to severe
anaphylaxis according to Sampson’s severity score, compared to 88% receiving intravenous glucocorticoids (p < 0.001)
and 91% receiving intravenous antihistamines (p < 0.001). Even in severe anaphylaxis (grade 5) adrenaline was
administered in only 80% of the cases.
Conclusion: Treatment with adrenaline is not administered in accordance with international guidelines. However,
making an assessment of the severity of the anaphylactic reaction is difficult in retrospective studies.
Keywords: Anaphylaxis, Pre-hospital treatment, Severity
Background
Anaphylaxis is a severe, life-threatening generalized
hypersensitivity reaction [1]. Population-based studies
have reported a prevalence of bee and wasp induced
anaphylaxis ranging from 0.3 to 8.9% in adults and from
0.15 to 0.8% in children [2, 3]. Several studies have re-
ported bee and wasp stings to be the most common trigger
of anaphylactic reactions in adults [4, 5]. The incidence of
fatalities due to bee and wasp induced anaphylactic re-
actions ranges from 0.3 to 0.48 cases per one million
inhabitants per year, representing around 20% of fatal
anaphylaxis from any cause [2, 3]. In Denmark, bee and
wasp induced anaphylactic reactions were reported to
be 40% of anaphylactic cases pre-hospital level in the
1980s [6] and the number of fatalities related to this
condition in Denmark was in the 1980s estimated to
one per year or 0.25 cases per 1,000,000 inhabitants per
year [7, 8]. No recent data are available in Denmark.
The first line treatment of anaphylaxis is intramuscular
(IM) administered adrenaline [9, 10]. However, a recent
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German study has shown that adrenaline is administered
in only 22.7% of anaphylaxis cases in the emergency set-
ting and only in 29.6% of cases with severe anaphylaxis
[11]. This is in line with previous studies in the emer-
gency department [12–14], reflecting poor concordance
between guidelines and actual treatment in the acute
situation in the emergency settings [11, 15].
Bee and wasp induced anaphylactic reactions are often
treated at a pre-hospital level. However, data of pre-
hospital treatment of anaphylaxis are sparse [5, 16, 17].
With this study, we aimed 1) to estimate the incidence
of bee and wasp induced anaphylactic reactions at pre-
hospital level in the Region of Southern Denmark
(2009–2014) and 2) the severity of the reactions, and 3)
to correlate pre-hospital treatment to the severity of
the anaphylactic reaction.
Methods
This is a retrospective and descriptive study based on
data from the Mobile Emergency Care Units (MECUs)
in the Region of Southern Denmark during the period
January 1st, 2008 to December 31st, 2014. During 2008
the MECU covered only the city of Odense with a popu-
lation of 187,138 persons. From 2009, however, the
emergency medical system in the Region of Southern
Denmark was expanded to consist of six MECUs servicing
the entire population of 1,201,366 persons and covering
an area of 122.00 km2. The Mobile Emergency Care Unit
(MECU) operates as part of a three-tiered system, in
which the MECU supplements an ordinary ambulance
manned with two emergency medical technicians (EMTs)
or a paramedic and an ambulance. The MECU consists
of a rapid response car manned with a specialist in
anesthesiology and an EMT [18].
Following each MECU run, the attending anesthesiologist
documents the mission in the MECU database including
registration of tentative diagnosis according to the Inter-
national Classification of Diseases 10 (ICD-10), vital signs,
treatment administered and outcome of mission [18, 19].
Discharge summaries with ICD-10 diagnosis: T63.4 Venom
of other arthropods (insect bite or sting, venomous), T78.2
Anaphylactic shock, unspecified, T78.3 Angioneurotic
edema, T78.4 Allergy, unspecified and I46.0 Cardiac ar-
rest with successful resuscitation, were extracted from
the MECU database and reviewed in order to identify
the cases of bee and wasp induced anaphylaxis.
Discharge summaries with anaphylaxis induced by other
triggers than bee or wasp were excluded, as well as the
summaries without any description of symptoms since
these could not be used to assess the severity of the ana-
phylactic reactions. In the case of patients encountered
more than once during the study period, only the first
contact was included, but the characteristics of the subse-
quent contacts were described.
The severity of the anaphylactic reaction was assessed
according to two severity score systems. We used
Sampson’s severity score (Table 1) [20] which was chosen
because it is the score that is used routinely in the Allergy
Center. It comprises a 5 grades scoring system that ranges
from mild (grade 1) to severe symptoms of anaphylaxis
(grade 5). Furthermore, we used Mueller’s severity score
(Table 2) [21], which is a 4 grades system designed for the
assessment of insect stings induced anaphylaxis. Treat-
ment was evaluated in relation to administration of adren-
aline IM, adrenaline intravenous (IV) or combination of
both, glucocorticoids IV and antihistamines IV. Data on
the population living in the city of Odense in 2008 and
in the Region of Southern Denmark during 2009–2014 were
collected at the StatBank Denmark website (http://www.
statistikbanken.dk; accessed November 2016).
Statistics
Baseline characteristics are presented as numbers and
percentages. The Incidence Rate (IR) of anaphylaxis was
calculated for the Region of Southern Denmark during
2009–2014 as the number of patients having anaphylaxis
for the first time per 1,000,000 person year with the
correspondent 95% confidence interval based on a binomial
distribution (CI 95%). Comparisons were made by χ2-based
table analysis. Statistical significance was defined as p <
0.05. Statistical analysis was performed with Stata IC
14.0 (Stata Corporation LP®, Texas, USA).
Ethics
The study was approved by the Danish National Board
of Health (J. no. 3–3013–911/1/) and the Data Protection
Agency (J. no. 15/4004). Approval by an Ethics Committee
or informed consent is not required for register-based
research in Denmark.
Results
We reviewed 710 discharge summaries. Two hundred
and seventy-three summaries (39%) fulfilled the inclusion
criteria of bee and wasp induced anaphylactic reactions.
Numbers of individuals at each stage of the study and rea-
sons for exclusion are presented in Fig. 1. The study popu-
lation included 88 women and 185 men with a median
age of 53 years; 20 children (0–17 years) and 253 adults
(18–91 years). Most cases were seen between May and
September. The Incidence Rate of bee and wasp induced
anaphylaxis was calculated in 35.8 cases per 1,000,000 per-
son year (95% CI 25.9–48.2) in the Region of Southern
Denmark during 2009–2014 (n = 259).
Three deaths were registered during the study period:
two men (46 and 63 years old) and one woman (80 years
old). In these three cases the symptoms were described
as follows: one had loss of consciousness, respiratory
and cardiac arrest; one was stung in the mouth with severe
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swelling and asystole; and the third one had hypotension
and loss of consciousness. Only the first patient received
treatment with adrenaline IV, glucocorticoids IV and anti-
histamines IV. The other 2 patients did not receive any
treatment as they were found dead at the MECU arrival.
The 3 deaths represented 1% of our study population
and a mortality rate of 0.4 cases per 1,000,000 person
year was calculated in the study period.
The group of patients with multiple encounters in-
cluded three men and two women. All were seen twice
in the period and had moderate to severe anaphylaxis
(grade 3–5) at the first contact and received treatment
with adrenaline IM, glucocorticoids IV and antihistamines
IV. At the second contact four of the five patients had
moderate to severe symptoms while one had grade 2
symptoms (generalized erythema and edema of the
Fig. 1 Flow diagram of patients with bee and wasp induced anaphylactic reaction attended by the MECU during 2008-2014
Table 2 Grading of anaphylaxis according to severity of clinical symptoms. Mueller 1966
Grade Signs and Symptoms
1 Slight general reaction Generalized urticaria, itching, malaise and anxiety
2 General reaction Any of the above plus two or more of following: generalized edema; constriction in chest; wheezing;
abdominal pain; nausea and vomiting; and dizziness
3 Severe general reaction Any of the above plus two or more of following: dyspnea; dysphagia; hoarseness or thickened speech;
confusion; and feeling of impending disaster
4 Shock reaction Any of the above plus two or more of following: cyanosis; fall in blood pressure; collapse incontinence;
and unconsciousness
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tongue). At the second contact all cases were treated
with glucocorticoids IV and antihistamines IV. Adren-
aline IM was administered to the four patients with
moderate to severe symptoms.
Severity of the anaphylactic reaction
All cases of bee and wasp induced anaphylactic reactions
could be graded according to Sampson’s severity score; 177
(65%) of the cases were graded as moderate to severe ana-
phylaxis (grade 3 to 5) (Fig. 2). Using Mueller’s score, 76
(28%) of the cases could not be graded (distributed in
Sampson’s severity score as grade 1 (n = 51), grade 2 (n = 3),
grade 3 (n = 4), grade 4 (n = 12) and grade 5 (n = 6)). There-
fore, Sampson’s severity score was used for further analysis.
Among the 20 children, most had local symptoms
(grade 1, n = 9) or had generalized skin symptoms (grade
2, n = 5), while 6 (30%) presented with moderate to severe
anaphylaxis. In the group of adults moderate to severe
anaphylaxis was observed in 171 (68%) patients.
Treatment in relation to the severity of the reaction
The administration of adrenaline, glucocorticoids and
antihistamines according to the severity of the anaphyl-
actic reaction is shown in Fig. 3.
Patients with moderate to severe anaphylaxis (n = 177)
received treatment with adrenaline in 54% (96/177) of
the cases (IM 78%, IV 8%, combination of both 14%),
compared to 88% (156/177) receiving intravenous gluco-
corticoids (p < 0.001) and 91% (162/177) receiving intra-
venous antihistamines (p < 0.001). Including only the
more severe reactions (grade 4 to 5) the results did not
change; hence, 56% (83/147) of the patients in grade 4–5
and, 80% (43/54) of the cases in grade 5, were treated
with adrenaline, respectively.
The proportion of cases with moderate to severe ana-
phylaxis treated with adrenaline was stable during the
study period (2008–2014) except for the year 2012,
where 26% of the cases received treatment with adren-
aline (data not shown). This was significantly lower
compared both to the previous years (p < 0.02) and the
following years (p < 0.02). The results were not changed
by only including grade 4 to 5.
Discussion
This is the first observational, retrospective study asses-
sing bee and wasp induced anaphylactic reactions at
pre-hospital level in Denmark. Our study reveals that
moderate to severe anaphylaxis was observed in 65% of
anaphylactic patients treated by the MECU in the Re-
gion of Southern Denmark. Furthermore, our results
showed that treatment with adrenaline in cases with
moderate to severe anaphylaxis was performed in only
half of the cases while most cases were treated with
glucocorticoids and antihistamines.
A few other studies have evaluated the severity of ana-
phylaxis induced by bee and wasp sting in the emergency
room [22, 23]. A recent study from Belgium shows that
67% of bee and wasp induced anaphylactic reactions were
grade 4–5 using Sampson’s severity score in line with our
pre-hospital findings [22], whereas a retrospective study in
a Swiss emergency department showed that only 6% were
graded as moderate to severe anaphylaxis using Mueller’s
severity score [23]. Using Mueller’s scoring system, we
were unable to classify 28% of the anaphylaxis cases in our
Fig. 2 Severity of the anaphylactic reaction evaluated by Sampson’s
severity score (a) and Mueller’s severity score (b) (n = 273)
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retrospective study. Using the Sampson’s severity score,
however, all patients could be classified. Sampson’s severity
score includes 5 grades from mild to severe anaphylaxis,
includes local symptoms and allowed scoring according to
single symptoms such as hypotension [20]. In Mueller’s se-
verity score, symptoms described in the milder grades of
anaphylaxis are mandatory to reach a higher severity grade
[21]. This means that in retrospective studies, when most
often only the most severe symptoms such as hypotension
or respiratory symptoms are described in details, Mueller’s
severity score is less suitable for evaluation. In our study
23% (22/76) of those that could not be classified by
Mueller’s severity score had moderate to severe anaphyl-
axis according to the Sampson severity score. This sup-
ports an issue previously discussed by Bilò et al [3] and
Golden et al [24]. They state that some of the frequently
used severity scores as Mueller’s [21] and Ring’s [25] do
not consider the possible absence of cutaneous symptoms
in the reaction. This risks misclassification of reactions
with isolated hypotension, as well reactions with symp-
toms from other organ systems than the skin, contributing
to a possible under-diagnosis of anaphylaxis [26].
In line with previous studies of anaphylaxis at pre-
hospital level [16, 27, 28] and in the emergency room
[11], our study shows that adrenaline was administered
in only 54% of patients with moderate to severe anaphyl-
axis whereas antihistamines and glucocorticoids were
administrated in nearly all cases. Not all symptoms in
Sampson’s severity score grade 3 require treatment with
adrenaline. However, including only the more severe re-
actions (Sampson’s grade 4–5) did not change the result
(54% versus 56%) and including only reactions classified
as Sampson’s grade 5, still only 80% received adrenaline.
The last finding supports an older pre-hospital study in
Scandinavia on severe anaphylactic reactions managed
by anesthesiologist-staffed ambulance helicopters [5],
showing that adrenaline is still administered in only
78–80% of the severe anaphylaxis cases. This is in contrast
with the current international guidelines for anaphylaxis
treatment [9, 10]. However, the low mortality rate ob-
served in this study, in line with previous Danish estimates
[7, 8] and international studies [2, 3], does not seem to re-
flect the lack of adrenaline administration.
Various factors may explain the reluctance to use
adrenaline in the acute treatment of moderate to severe
anaphylaxis. Firstly, the MECU is served by a specialist
in Intensive Care Medicine which closely observes the
patient and the vital parameters. The real clinical situ-
ation could be different than the data obtained from the
files retrospectively suggests. The recording of a respir-
ation rate above the normal rate could retrospectively be
considered a case of respiratory insufficiency, while it in
fact might simply be hyperventilation caused by fear and
anxiety. Furthermore, in the acute situation, treatment
of respiratory symptoms with β2-agonist inhalation may
have resolved the symptoms and in some cases the pa-
tient may recover spontaneously even without adminis-
tration of adrenaline. Also, in some cases, a pre-existing
cardiovascular condition may have affected the decision
whether to use adrenaline or not.
The appropriateness of administration of adrenaline in
patients with anaphylaxis has recently been discussed in
one study in the emergency care setting where even
though more than 60% of the patients with anaphylaxis
did not receive adrenaline, the allergists-immunologists
found that the management of the reaction was appro-
priate in 98% of the cases [29].
Despite this, it is necessary to comprehend the import-
ance of the treatment with adrenaline due its effect on
α-1, β-1 and β-2 receptors, reversing the life-threatening
Fig. 3 Treatment administrated by the MECU in relation to the severity of the anaphylactic reaction
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symptoms of anaphylaxis [10], but at the same time the
assessment of the physician on charge is determinant
and it should not be underrated.
Among the limitations of this study are: The retro-
spective design; the classification of the reactions in the
scoring systems was not performed by the emergency
physicians in the acute settings; the assessment was done
retrospectively based on the described symptoms in the
discharge summaries; the discharge summaries may not
necessarily include all symptoms as they may only in-
clude the most severe symptom, and the course of the
reaction was not always clearly described. This may bias
the results. Furthermore, data including evaluation of
Serum-tryptase (both during the reaction and at basic),
and specific Serum-IgE to venom were not available as
well as co-morbidity such as mastocytosis and co-factors
such as NSAID or exercise.
The strengths of this study are the size of the popula-
tion, the long time span (2008–2014) and the fact that the
MECU includes treatment at pre-hospital level, where the
majority of bee and wasp induced anaphylactic reactions
take place. Also, the character of the emergency care sys-
tem with MECUs being dispatched to all perceived se-
verely ill patients in the region ensures that most of the
patients being affected by bee and wasp induced anaphyl-
actic reactions were registered [30]. Likewise, the Danish
Civil Registration number system [31] ensures that the
discharge summary of every patient encountered by the
MECU can be accessed in the patient’s in-hospital medical
files.
Conclusion
Assessment of the severity of the anaphylactic reaction
is difficult in retrospective studies due the lack of de-
scription of all signs and symptoms.
Although adrenaline is first choice of drug in cases of
anaphylaxis and thus of higher priority than glucocorti-
coids and antihistamines, this was administered to a lesser
extent than the two latter drugs. There seems to be a po-
tential for improving prehospital physicians adherence to
guidelines.
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